• Overcome Formulation Challenges Of Protein-based Therapeutics
    Overcome Formulation Challenges Of Protein-based Therapeutics

    Protein-based therapeutics have emerged as a key driver of growth in the pharmaceutical industry. R&D pipelines have filled with biologics and monoclonal antibodies have become the best-selling drugs around the world. Despite the success of this segment, the size and complexity of protein molecules create specific challenges when developing these types of therapeutics.

  • Streamlining Recombinant Protein Production

    Use of recombinant proteins as therapeutics has become an attractive strategy for altering the biology of disease progression and offers significant commercial opportunities.  However, bringing a recombinant protein to market requires a substantial investment of time and resources, and the process is generally complex and subject to technical pitfalls.

  • A Cure For Pharmaceutical Supply Chain Complexity

    The pharmaceutical industry lags in the sophistication and performance of its supply chains when they are compared with best-in-class companies in other industries. This is due to the complexity that has come with new drugs, more complex production technologies and evolving regulatory requirements. In this environment, integrating and aligning the supply chain makes it more flexible, bolstering operational performance and financial competitiveness.

  • Best Practices In Supply Chain Management: A CMO Perspective

    Supply chain management has advanced rapidly over the past decade, evolving from what was once dubbed “materials management” into the essential glue that binds all aspects of a business’ internal and external collaborations.

  • Key Considerations When Choosing A Partner For Drug Discovery

    The changes in the economic landscape and pipelines over the last 10-15 years have resulted in drug developers in companies of all sizes to take a hard look at their strategy and operations.

More From Featured Articles


Carboxyfluorescein Caspase Detection Kits Carboxyfluorescein Caspase Detection Kits
Apo Logix Carboxyfluoroscein Caspase Detection Kits label active caspases in living cells undergoing apoptosis
Labware Catalog
The Platinum Labware catalog features a comprehensive range of platinum labware specifically fabricated from materials such as platinum, platinum/gold non-wetting alloys, rhodium/platinum alloys, and zirconia grain stabilized (ZGS) platinum gold alloy...
Sample Clean-Up System Sample Clean-Up System
The Prospekt-2 high-speed sample clean up couples to LC, LC-MS, or GC systems...
Screening Platform Screening Platform
An integral part of the UHTSS is the Nanoplate, which is a screening platform that has 3,456 miniaturized wells in
Drug Process Development Drug Process Development

Althea’s complete range of drug Process Development capabilities offers the tools to address your needs. We develop processes for producing small quantities of proteins for early testing or establish robust, reliable and scalable processes that enable a strong commercial advantage. Althea also provides access to a proprietary drug delivery platform, called Crystalomics® technology, for the development of alternative drug delivery formulations of second generation drug substances.

Liquid-Liquid Extraction System Liquid-Liquid Extraction System
The Myriad Automated Liquid-Liquid Extractor (ALLEX) provides fully automated liquid-liquid extraction between many combinations of immiscible liquids...
More Featured Products